The article credits the increased use of GLP-1 drugs, and reports that about 1 in 8 adults now use one of them
Preventing Weight Regain During the Transition The 4-6 week window after switching from Zepbound to Foundayo is the highest-risk period for weight regain
DeFronzo, MD Professor of Medicine Chief of the Diabetes Division University of Texas Health Science Center at San Antonio Disclosures: DeFronzo reports serving on an advisory board for Aardvark, Alnylam, AstraZeneca, Boehringer Ingelheim, Corcept, Intarcia, Novo Nordisk and Renalytix
Never place vials directly against freezer coils or allow ice crystals to form on the outer label
FDA approved semaglutide delivers a verified dose and a formulation that has been tested in large trials, so weight loss expectations and titration steps are standardized